Bausch Health Companies Inc.’s consumer health business is a “recovery in progress” as US revenues grew 11% on sales of eye drops and vision care supplements to push its global results up 1% in the third quarter to $374m.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?